World's Best Scientists 2026 revealed!
Irvin M. Modlin

Irvin M. Modlin

D-Index & Metrics

Medicine

D-Index
93
Citations
37505
World Ranking
10771
National Ranking
5542

Overview

Irvin M. Modlin is affiliated with Yale University in the United States and has contributed extensively to research in the field of medicine, with a particular focus on neuroendocrine tumors and oncology. Their work spans multiple subfields including epidemiology, oncology, neurology, pulmonary and respiratory medicine, and cancer research.

The scientist's research topics cover several specialized areas including:

  • Neuroendocrine Tumor Research Advances
  • Lung Cancer Research Studies
  • Neuroblastoma Research and Treatments
  • Prostate Cancer Treatment and Research
  • Radiopharmaceutical Chemistry and Applications
  • Cancer, Lipids, and Metabolism
  • Pancreatic and Hepatic Oncology Research

Irvin M. Modlin has coauthored papers frequently with several researchers, including:

  • Mark Kidd
  • Lisa Bodei
  • Anna Malczewska
  • Ignat Drozdov
  • Alexandra Kitz

Their work has been published repeatedly in established scientific venues, with frequent contributions appearing in:

  • Journal of Clinical Oncology
  • Current Opinion in Endocrine and Metabolic Research
  • Annals of Surgical Oncology
  • Annals of Surgery
  • Cancer Research

Selected recent papers authored or coauthored by Irvin M. Modlin include:

  • "Molecular profiling of neuroendocrine tumours to predict response and toxicity to peptide receptor radionuclide therapy," 2020, The Lancet Oncology
  • "A multigenomic liquid biopsy biomarker for neuroendocrine tumor disease outperforms CgA and has surgical and clinical utility," 2021, Annals of Oncology
  • "Treatment of advanced gastroenteropancreatic neuroendocrine neoplasia, are we on the way to personalised medicine?," 2021, Gut
  • "Early Identification of Residual Disease After Neuroendocrine Tumor Resection Using a Liquid Biopsy Multigenomic mRNA Signature (NETest)," 2021, Annals of Surgical Oncology
  • "Molecular Genomic Assessment Using a Blood-based mRNA Signature (NETest) is Cost-effective and Predicts Neuroendocrine Tumor Recurrence With 94% Accuracy," 2021, Annals of Surgery

Best Publications

  • A 5‐decade analysis of 13,715 carcinoid tumors

    Irvin M. Modlin M.D.;Kevin D. Lye;Mark Kidd

  • Gastroenteropancreatic neuroendocrine tumours.

    Irvin M Modlin;Kjell Oberg;Daniel C Chung;Robert T Jensen

  • Current status of gastrointestinal carcinoids.

    Irvin M. Modlin;Mark Kidd;Igor Latich;Michelle N. Zikusoka

  • The Epidemiology of Gastroenteropancreatic Neuroendocrine Tumors

    Ben Lawrence;Bjorn I. Gustafsson;Anthony Chan;Bernhard Svejda

  • American Gastroenterological Association Medical Position Statement on the Management of Gastroesophageal Reflux Disease

    Peter J. Kahrilas;Nicholas J. Shaheen;Michael F. Vaezi

  • The diagnosis and management of adult intussusception.

    Dennis G. Begos;Andras Sandor;Andras Sandor;Irvin M. Modlin;Irvin M. Modlin

  • Neuroendocrine tumor epidemiology: contrasting Norway and North America.

    Oyvind Hauso;Bjorn I. Gustafsson;Bjorn I. Gustafsson;Mark Kidd;Helge L. Waldum

  • Bronchopulmonary neuroendocrine tumors

    Bjorn I. Gustafsson;Bjorn I. Gustafsson;Mark Kidd;Anthony Chan;Max V. Malfertheiner

  • Diagnosis, objective assessment of severity, and management of acute pancreatitis. Santorini consensus conference.

    Dervenis C;Johnson Cd;Bassi C;Bradley E

  • Recommendations for management of patients with neuroendocrine liver metastases

    Andrea Frilling;Irvin M. Modlin;Mark Kidd;Christopher Russell

  • Review article: somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine (carcinoid) tumours.

    I. M. Modlin;M. Pavel;M. Kidd;B. I. Gustafsson

  • Chromogranin A—Biological Function and Clinical Utility in Neuro Endocrine Tumor Disease

    Irvin M. Modlin;Bjorn I. Gustafsson;Bjorn I. Gustafsson;Steven F. Moss;Marianne Pavel

  • Hypothermia and Acidosis Worsen Coagulopathy in the Patient Requiring Massive Transfusion

    A. Ferrara;J. D. Macarthur;H. K. Wright;I. M. Modlin

  • Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors

    Lisa Bodei;Mark Kidd;Giovanni Paganelli;Chiara M. Grana

  • Objective quantification of the Ki67 proliferative index in neuroendocrine tumors of the gastroenteropancreatic system: a comparison of digital image analysis with manual methods.

    Laura H. Tang;Mithat Gonen;Cyrus Hedvat;Irvin M. Modlin

  • Gastric carcinoid tumors: the biology and therapy of an enigmatic and controversial lesion.

    C J Gilligan;G P Lawton;L H Tang;A B West

  • Consensus on biomarkers for neuroendocrine tumour disease

    Kjell Oberg;Irvin M Modlin;Wouter De Herder;Marianne Pavel

  • A 50-year analysis of 562 gastric carcinoids: small tumor or larger problem?

    Irvin M Modlin;Kevin D Lye;Mark Kidd

  • Mediation of the trophic effects of short-chain fatty acids on the rat jejunum and colon.

    Wendy L. Frankel;Wel Zhang;Anudeep Singh;David M. Klurfeld

  • Priorities for Improving the Management of Gastroenteropancreatic Neuroendocrine Tumors

    Irvin M. Modlin;Steven F. Moss;Daniel C. Chung;Robert T. Jensen

Frequent Co-Authors

Mark Kidd
Mark Kidd Wren Laboratories
James R. Goldenring
James R. Goldenring Vanderbilt University
Laura H. Tang
Laura H. Tang Memorial Sloan Kettering Cancer Center
Dik J. Kwekkeboom
Dik J. Kwekkeboom Erasmus University Rotterdam
Giovanni Paganelli
Giovanni Paganelli Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori
Eric P. Krenning
Eric P. Krenning Erasmus University Rotterdam
Kjell Öberg
Kjell Öberg Uppsala University
Marc D. Basson
Marc D. Basson University of North Dakota
Walter E. Longo
Walter E. Longo Yale University
Shrikant Mane
Shrikant Mane Yale University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re passionate about healthcare but considering alternative pathways to traditional medical school, there are several high-quality online degrees that can prepare you for rewarding roles in the field. For registered nurses seeking to advance their careers, options like adn to np bridge programs offer a flexible route to become a nurse practitioner without interrupting your work schedule.

Prospective students interested in nutrition and wellness can pursue an online nutritionist degree, which will equip you with science-based knowledge for a career as a nutritionist or dietitian. Similarly, those aiming for leadership roles in healthcare management can explore the best mha programs offered online and accredited by CAHME.

For nurses who want to earn a bachelor’s degree without the need for in-person clinicals, there are now rn to bsn online no clinicals pathways available, making higher education more accessible than ever.

Exploring these diverse online degree options can open doors to a variety of career opportunities within the ever-evolving world of healthcare.

Best Scientists Citing Irvin M. Modlin

Trending Scientists

Recently Published Articles